These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5805289)

  • 21. Functional and stric characteristics of modified thrombin zymogen.
    Marciniak E
    Thromb Diath Haemorrh; 1970 Dec; 24(3):361-72. PubMed ID: 5503937
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolation and characterization of single chain bovine factor V.
    Nesheim ME; Myrmel KH; Hibbard L; Mann KG
    J Biol Chem; 1979 Jan; 254(2):508-17. PubMed ID: 762076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation and association of the oligomeric forms of factor V.
    Philip G; Moran J; Colman RW
    Biochemistry; 1970 May; 9(10):2212-8. PubMed ID: 5462520
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on blood coagulation factor V. I. The interaction of salts of fatty acids and coagulation factors.
    Kahn MJ; Hemker HC
    Thromb Diath Haemorrh; 1969 Dec; 22(3):417-30. PubMed ID: 5382283
    [No Abstract]   [Full Text] [Related]  

  • 25. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
    Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
    Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H; Markwardt F; Perlewitz J
    Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
    [No Abstract]   [Full Text] [Related]  

  • 27. Factor V and thrombin.
    Newcomb TF; Hoshida M
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:61-9. PubMed ID: 5862566
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
    Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PURIFICATION AND PROPERTIES OF BOVINE FACTOR V: A CHANGE OF MOLECULAR SIZE DURING BLOOD COAGULATION.
    PAPAHADJOPOULOS D; HOUGIE C; HANAHAN DJ
    Biochemistry; 1964 Feb; 3():264-70. PubMed ID: 14163951
    [No Abstract]   [Full Text] [Related]  

  • 30. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases.
    Dharmawardana KR; Bock PE
    Biochemistry; 1998 Sep; 37(38):13143-52. PubMed ID: 9748321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and properties of the thrombin-like enzyme from Trimeresurus gramineus venom.
    Ouyang C; Yang FY
    Biochim Biophys Acta; 1974 Jun; 351(2):354-63. PubMed ID: 4407153
    [No Abstract]   [Full Text] [Related]  

  • 32. The kinetics of inhibition of the action of thrombin by the fibrinopeptides formed during the clotting of fibrinogen.
    Silver A; Murray M
    Thromb Diath Haemorrh; 1966 Jul; 16(1):277-95. PubMed ID: 6011260
    [No Abstract]   [Full Text] [Related]  

  • 33. Simulation model for thrombin generation in plasma.
    Willems GM; Lindhout T; Hermens WT; Hemker HC
    Haemostasis; 1991; 21(4):197-207. PubMed ID: 1794746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prufication of bovine thrombin by affinity chromatography on benzamidine-agarose.
    Schmer G
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):810-4. PubMed ID: 4262631
    [No Abstract]   [Full Text] [Related]  

  • 35. Kinetic properties and molecular size of thrombin-activated favtor V.
    Colman RW; Moran J; Philip G
    J Biol Chem; 1970 Nov; 245(22):5941-6. PubMed ID: 5530157
    [No Abstract]   [Full Text] [Related]  

  • 36. Ac-globulin (Factor V): preparation of a practical product.
    Dombrose FA; Yasui T; Roubal Z; Roubal A; Seegers WH
    Prep Biochem; 1972; 2(4):381-96. PubMed ID: 4673387
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom.
    Tan NH
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
    Ofosu FA
    Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A method for preparation of dry thrombin for topical application.
    Tsvetkov T; Bucureshtliev A; Alexiev N; Nicolov C; Bucureshtlieva R; Mincheff M
    Cryobiology; 1984 Dec; 21(6):661-3. PubMed ID: 6518803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of the carbohydrate constituents of bovine thrombin for the clotting activity.
    Skaug K; Christensen TB
    Biochim Biophys Acta; 1971; 230(3):627-9. PubMed ID: 4397223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.